Products for Research Use Only
RegisterLogin

Anticancer agent 272

CAT: 0931-T207466-01Size: 10 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0931-T207466-01Size:10 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Target
Reactive Oxygen Species, Apoptosis, Ferroptosis
Related Pathways
Apoptosis, Immunology/Inflammation, NF-κB, Metabolism
Bioactivity
Anticanceragent 272 (Compound 2) is an anticancer agent demonstrating significant activity against bladder cancer cells (T-24) with an IC50 of 2.81 μM. It depletes glutathione (GSH) through a Fenton-like reaction, generating reactive oxygen species (ROS) and hydroxyl radicals (•OH), thereby inducing apoptosis and ferroptosis. Anticanceragent 272 enhances chemodynamic therapy (CDT) and promotes tumor cell death through mitochondrial dysfunction and autophagy. It holds potential for further research in bladder cancer.
Molecular Formula
C26H34Br2Cl4Cu2N8
Shipping Conditions
Ice Packs
Storage Temperature
-20°C

Related Products

CatalogName
T206255-01Antibacterial agent 272
T210648-01Anticancer agent 274
T210037-01Anticancer agent 239
T210028-01Anticancer agent 221
T209840-01Anticancer agent 213
T209412-01Anticancer agent 189
T209339-01Anticancer agent 196
T209334-01Anticancer agent 195
T206688-01Anticancer agent 270
T206158-01Anticancer agent 268

Alternative Products

CatalogName
C8452-10Anticancer agent 43
HY-155158Anticancer agent 147
HY-146040Anticancer agent 47
HY-158392Anticancer agent 219
HY-139711Anticancer agent 13
HY-170527Anticancer agent 260
HY-157931Anticancer agent 192
HY-147968Anticancer agent 74
HY-146407Anticancer agent 53
HY-115960Anticancer agent 35

Popular Products